U.K. Pitches Radical Investment Plans to Fight Killer Bacteria
Britain will push the world’s biggest economies to develop new ways to pay for the fight against drug-resistant bugs, including a Netflix-style subscription plan for antibiotics aimed at stimulating a broken market, according to a person familiar with the matter.
The U.K. wants to encourage drugmakers to develop new antibiotics amid fears that Covid-19 is obscuring the march of antimicrobial resistance (AMR), which it views as a “silent pandemic,” the person said. Drug-resistance already kills hundreds of thousands of people each year and risks undermining health systems worldwide.
The issue is normally part of Group of Seven health discussions rather than a finance issue. But the British government, which hosts a meeting of finance ministers next month, argues that at its core AMR is an economic problem and requires the world’s biggest markets to act together.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.